Optellum Joins J&J’s Lung Cancer Initiative
Executive Summary
Optellum’s Virtual Nodule Clinic artificial intelligence technology will be part of Johnson & Johnson’s Lung Cancer Initiative, an ongoing research program intended to improve lung cancer survival rates through early intervention and prevention.
You may also be interested in...
New Trial Shows BENEFIT Of J&J/Auris’ Monarch Bronchoscopy Platform
New published results demonstrate J&J/Auris’ robotic is safe and effective at diagnosing peripheral pulmonary lesions.
Veracyte, J&J Launch NOBLE Trial For Lung Cancer Detection
The 9,000-patient clinical study will identify genomic and other differences in lung cancer development and progression among patients with lung nodules detected by computed tomography.
Tech Transfer Roundup: Amgen Teams With MD Anderson To Accelerate Early-Stage Cancer Candidates
In a busy month, MD Anderson also partners with Ipsen on an unspecified cancer drug and licenses poziotinib IP to Spectrum. Using IP from UCLA, Bloom launches with focus on neuroprotective epilepsy therapies.